IN RE: DURANCE
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
Federal Circuit Summary
Before Lourie, Reyna, and Chen. Appeal from the Patent Trial and Appeal Board (“PTAB”).
Summary: Nothing in § 41.41(b)(2) bars a reply brief from addressing new arguments raised in the examiner’s answer that are not articulated in the Final Office Action, regardless of whether the examiner designated the new argument as a new ground of rejection.
Timothy D. Durance, Jun Fu, and Parastoo Yaghmaee (“Applicant”) appeal a decision from the PTAB affirming an examiner’s obviousness rejection. The examiner issued a final office action rejecting all of Applicant’s claims as obvious in view of the cited references. On appeal to the PTAB the examiner advanced new arguments in support of the rejection, but did not designate these arguments as new grounds of rejection. In its reply brief Applicant rebutted these new arguments, but the PTAB disregarded them, stating the arguments were “not responsive to an argument raised in the Answer.” Applicant requested a rehearing, averring that the arguments in its reply brief were improperly ignored. The PTAB denied the request for rehearing.
The Federal Circuit vacated the PTAB’s decision and remanded for consideration of the arguments advanced in Applicant’s reply brief. The Court found that if an examiner’s answer includes arguments raised for the first time, an applicant may address those arguments in the reply. Here, Applicant’s reply brief was responsive to the examiner’s answer and included citations indicating the new arguments they were replying to. Therefore, the Federal Circuit found it was an error for the PTAB to disregard these arguments.
This case is: IN RE: DURANCE
Edited by: Paul Stewart
Written by: Jacob R. Rosenbaum and Christie Matthaei
More insights
Fresh From the Bench: Latest Precedential Patent Case
Ridge Corp. et al. v. Kirk NationaLease Co. et al. , Appeal No. 2025-1254 (Fed. Cir. July 13, 2026) In its only precedential patent opinion last week, the Federal Circuit considered an appeal of a preliminary injunction issued by the U.S. District Court…
Fresh From the Bench: Latest Precedential Patent Cases
CASE OF THE WEEK Wyeth LLC v. AstraZeneca Pharmaceuticals LP , Appeal No. 2024-2325 (Fed. Cir. July 9, 2026) In our Case of the Week, the Federal Circuit affirmed a district court ruling reversing a $107.5 million jury verdict against AstraZeneca in a case…
Enanta Pharmaceuticals, Inc. v. Pfizer Inc., Appeal No. 2025-1427 (Fed. Cir. Jun. 23, 2026)
CASE OF THE WEEK Enanta Pharmaceuticals, Inc. v. Pfizer Inc., Appeal No. 2025-1427 (Fed. Cir. Jun. 23, 2026) In our Case of the Week, the Federal Circuit affirmed summary judgment invalidating all claims of Enanta’s Patent No. 11,358,953 as…